ESCALON MEDICAL CORP
10-K September 29, 2025
Key Highlights
- First positive cash flow in years with $12.05M total revenue (up 0.5%)
- R&D spending increased 9.4% ($753k) focused on new AXIS product line
- Maintains $6.53M tax loss credits enabling 0% tax rate
Read Analysis
🤖 AI Generated